Two Different Therapeutic Approaches for SARS-CoV-2 in hiPSCs-Derived Lung Organoids
The global health emergency for SARS-CoV-2 (COVID-19) created an urgent need to develop new treatments and therapeutic drugs.In this study, we tested, for the first time on human cells, a MENO SUPPORT COMPLEX new tetravalent neutralizing antibody (15033-7) targeting Spike protein and a synthetic peptide homologous to dipeptidyl peptidase-4 (DPP4) r